Can a Dedicated Chronic Limb-threatening Ischaemia (CLTI) Clinic Improve Patient Self-reported Quality of Life
Key facts
- Who runs it
- The Leeds Teaching Hospitals NHS Trust
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 17 Nov 2022
- Ended
- 1 Aug 2024
- Type of study
- Observational
- Treatments tested
- CLTI Clinic
- Record updated
- 14 February 2025
Who can take part
- Age
- 18 years to 105 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- All patients seen and assessed in the CLTI clinic
Who cannot take part
- Patients with chronic venous insufficiency
- Patients with diabetic foot infection
- Patients with significant cognitive impairment such that they are unable to answer the questions
- Patients without a confirmed diagnosis of CLTI
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
CLTI is the most severe form of peripheral arterial disease. Patients with the condition require investigation and management (typically in the form of revascularisation surgery) to salvage the limb. Traditionally, patients with the condition are admitted into hospital for their management, but with the advent of regional vascular networks, this is becoming increasingly difficult.
Read full original descriptionShow less
Recently, the Vascular Society of Great Britain and Ireland have advocated for the use of dedicated CLTI clinics to overcome this problem. Whilst there is burgeoning evidence for their clinical benefit, there is a lack of patient reported outcomes to measure their impact on patient selr-reported quality of life. We would like to determine if this service benefits its users as much as the clinical outcomes suggest it does.
The group in the trial
- CLTI clinic patients
This is a repeated measures study design. Eligible patients are opportunistically recruited into the study, and if successfully enrolled are given the EuroQoL 5-D to complete. Whether they undergo a revascularization procedure or not, the EuroQol 5-D is administered again at 6-12 weeks and again at 1 year after their initial assessment
Treatment: CLTI Clinic
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Can a Dedicated Chronic Limb-threatening Ischaemia (CLTI) Clinic Improve Patient Self
- Record updated
- 14 February 2025